Blue Arrow Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Blue Arrow Capital Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-94,641	Closed	-$1.21M	–	184
2014 Q4	$1.21M	Sell	94,641 -1,345	-1%	-$15.4K	0.14%	132
2014 Q3	$1.04M	Buy	+95,986	New	+$1.1M	0.11%	145
2014 Q2	–	Sell	-18,626	Closed	-$192K	–	159
2014 Q1	$192K	Buy	+18,626	New	+$209K	0.03%	105

Other funds holding IRWD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Blue Arrow Capital Management's IRWD Position: Q1 2015 in Review

Blue Arrow Capital Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2015, closing a stake of 94,641 shares — an estimated $1.21M sold.

Blue Arrow Capital Management first reported a position in IRWD in Q1 2014 and held it in 3 quarters. The position peaked at $1.21M in Q4 2014. 142 funds tracked by Wall St. Rank hold IRWD as of Q1 2015.

Blue Arrow Capital Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
Blue Arrow Capital Management sold 94,641 Ironwood Pharmaceuticals shares in Q1 2015, an estimated $1.21M.
Blue Arrow Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2014 and held it in 3 quarters.
Blue Arrow Capital Management's Ironwood Pharmaceuticals position peaked at $1.21M in Q4 2014.
142 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2015.

Based on Blue Arrow Capital Management's 13F filing for Q1 2015, filed 15 May 2015.